October/November #183 : Finding an HIV Vaccine - by Cristina González

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Features

The Show Must Go On

A Capital Affair

From the Editor

Trench Warfare

Feedback

Letters- October/November 2012

The POZ Q+A

Full-Court Press

What You Need to Know

Jamar Rogers's Voice Will Go On

Olympic Winner Tells the World He's Positive

Pesky Email Spam Offers Clues for Eradicating HIV

Infant Circumcision Grows to Global Debate

Why Folks With HIV Can Be Excellent Transplant Recipients

We Hear You

Dr. No

POZ Survey Says

Taking Risks to Help Others

What Matters to You

Finding an HIV Vaccine

Treatment News

Detecting the Missing Link Between HIV and Brain Drain

Point of Reentry: Getting Prisoners HIV Care

New Booster in Town: Cobicistat

Bronx Cheer: An HIV Testing Program Shows Progress

The "War on Drugs" Spreads HIV

Comfort Zone

Dear Diary

POZ Heroes

Hip-Hop Soul

   
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

October / November 2012

Finding an HIV Vaccine

by Cristina González

1. The Issue
While HIV meds can keep positive people healthy and simultaneously lower their risk of spreading the virus, too few people have access to treatment for it alone to stop the epidemic. Of the 34 million people with HIV on the planet, only 8 million are taking life-sustaining antiretrovirals. What’s more, the rate at which people become infected is outpacing the rate at which people access care. For each person who starts treatment, two more become positive. Every day, more than 7,000 people globally contract HIV. Clearly, an effective strategy to end AIDS must include a preventive vaccine.  

Therapeutic vaccines could also play a role for people living with HIV. Such vaccines could help their bodies control the virus, meaning they wouldn’t have to take daily meds. So for everyone, vaccines are an essential ingredient in the end of AIDS.

Since the virus that causes AIDS was discovered in 1983, only three major vaccine trials have been completed. The first trial, called AIDSVAX, failed 
to prevent or control the virus. The second trial, MRKAd5, was discontinued 
because it possibly increased infection risk. The last trial, RV144, was mildly successful, lowering the rate of HIV infection by about 31 percent.

Since then, significant scientific progress has been made, especially in the area of discovering HIV-neutralizing antibodies and developing vaccines to prompt the immune system to produce more of them, but further research is needed. Vaccine development takes time. Focused efforts to develop an HIV vaccine have only been under way since the mid-’90s. By comparison, the polio vaccine took nearly 50 years to develop.

Vaccine research also requires money. The more funding we invest, the faster we’ll make progress.

2. Why This Matters to You
From chicken pox to polio, vaccines have become one of the most powerful public health interventions available, eradicating or lowering instances of an infection. They are effective, easy to administer and require no long-term commitments from individuals. And vaccines offer an equal opportunity for self-protection among disenfranchised groups (like women, gay men, people of color, children and sex workers).

3. What You Can Do About It
Support vaccine research. Volunteer your time, donate money and use your voice. Call your AIDS service organizations and members of Congress and ask them to support initiatives for vaccine research. Do it loudly, and do it often. And talk to your doctor about volunteering for a clinical trial or study. Finally, if you can, spare a few dollars for vaccine efforts. Find out more about vaccine research at the International AIDS Vaccine Initiative’s web site iavi.org.

Search: preventive vaccine, therapeutic vaccine, AIDSVAX, MRKAd5, RV144, International AIDS Vaccine Initiative

Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Is youth leadership important in the HIV/AIDS fight?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.